Canada not affected by U.S. EpiPen recall
CBC | Health News
A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S., Europe, Asia and South America because the allergy shots may not work.
Health Canada is launching a second set of public consultations about a controversial plan to revamp regulations governing self-care products such as natural health remedies, cosmetics and over-the-counter medications.
Researchers have begun the second phase of testing of a Zika vaccine developed by U.S. government scientists in a trial that could yield preliminary results as early as the end of 2017.
No comments:
Post a Comment